806.40—Public availability of reports.
               		
               	 	
               	 	
               	 	               	 	               	 	               	 	               	 	
               	 	
    
        
        (a) 
         Any report submitted under this part is available for public disclosure  in accordance with  part 20 of this chapter.
     
    
        
        (b) 
         Before public disclosure of a report, FDA will delete from the report:
     
    
        
        (1) 
         Any information that constitutes trade secret or confidential commercial or financial information under  § 20.61 of this chapter; and
     
    
        
        (2) 
         Any personnel, medical, or similar information, including the serial numbers of implanted devices, which would constitute a clearly unwarranted invasion of personal privacy under  § 20.63 of this chapter or 5 U.S.C. 552(b)(6); provided, that except for the information under  § 20.61 of this chapter or 5 U.S.C. 552(b)(4), FDA will disclose to a patient who requests a report all the information in the report concerning that patient.